newsfilter
← Latest News
ACCESS Newswire·

MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting

Following topline results expected in the coming weeks, the oral session at ASH 2023 in December will provide detailed findings from MANIFEST-2Investor event focused on MANIFEST-2 with MorphoSys management and medical